Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study of Patients With Barrett's Esophagus-Associated Neoplasia Receiving Ursodeoxycholic Acid in the Setting of Endoscopic Ablation

NCT07756710 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT07756710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07756710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study of Patients With Barrett's Esophagus-Associated Neoplasia Receiving Ursodeoxycholic Acid in the Setting of Endoscopic Ablation
Lead sponsor
Columbia University
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 30, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett's esophagus with dysplasia